These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


318 related items for PubMed ID: 9715299

  • 1. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
    Mehta YS, Badakere SS.
    J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
    [Abstract] [Full Text] [Related]

  • 2. Recombinant anti-idiotypic antibodies inhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies.
    Escher R, Vogel M, Escher G, Miescher S, Stadler BM, Berchtold P.
    J Autoimmun; 2002 Feb; 18(1):71-81. PubMed ID: 11869049
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Study on autoimmune thrombocytopenic purpura related antibody].
    Lu L, Hou M, Shi Y, Qin P, Peng J, Zhu YY, Zhang MH.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):477-9. PubMed ID: 14575592
    [Abstract] [Full Text] [Related]

  • 8. [Identification of human platelet specific functional antibody and its fragments].
    Chu XX, Hou M, Zhu YY, Peng J, Ji XB, Zhang F, Wang L.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 28; 85(49):3464-8. PubMed ID: 16686061
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis.
    Feistauer SM, Penner E, Mayr WR, Panzer S.
    Hepatology; 1997 Jun 28; 25(6):1343-5. PubMed ID: 9185750
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The isolation and characterisation of antiplatelet antibodies.
    Hamidpour M, Behrendt M, Griffiths B, Partridge L, Lindsey N.
    Eur J Haematol; 2006 Apr 28; 76(4):331-8. PubMed ID: 16519705
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antiplatelet antibodies in childhood idiopathic thrombocytopenic purpura.
    Ozsoylu S.
    Am J Hematol; 1996 Apr 28; 51(4):328. PubMed ID: 8602636
    [No Abstract] [Full Text] [Related]

  • 17. Harmful and beneficial antibodies in immune thrombocytopenic purpura.
    Imbach PA.
    Clin Exp Immunol; 1994 Jul 28; 97 Suppl 1(Suppl 1):25-30. PubMed ID: 8033430
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ, Balthasar JP.
    Clin Lab; 2004 Jul 28; 50(3-4):133-40. PubMed ID: 15074465
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.